Objective Tapering of selective serotonin reuptake inhibitor (SSRI) therapy, as opposed to
abrupt discontinuation, has been recommended by several guidelines and in the literature in …

The selective serotonin reuptake inhibitor paroxetine has been extensively studied and is
now an established therapy for the treatment of depressive disorders. Paroxetine has …

Depressive illness is now recognised as a major health problem. As many patients do not
need indefinite treatment, clinicians need to be aware of the symptoms associated with the …

Objectives It is a naturalistic, retrospective, observational study which objective is to evaluate
and compare the pattern of antidepressant use (fluoxetine, fluvoxamine, paroxetine …

BackgroundThere has been a recent rise in antidepressant prescriptions. After the episode
for which it was prescribed, the patient should ideally be supported in withdrawing the …

Antidepressant discontinuation symptoms occur with all classes of antidepressant. A well-
described discontinuation syndrome occurs with the selective serotonin reuptake inhibitors …

Therapeutic Advances in Psychopharmacology 10 2 journals. sagepub. com/home/tpp
expressed hesitation about coming off your current antidepressant. Your concern is …

Paroxetine is a new selective serotonin reuptake inhibitor which has been extensively
evaluated as an antidepressant in clinical trials and a large computerzed safety database …

More than 10% of adults are prescribed antidepressants annually in some countries. Recent
increases in prescribing can be explained more by repeat prescriptions than new patients …

Introduction Prescription rates for antidepressants (ADs) are high and continue to increase,
despite evidence of significant adverse effects, including withdrawal symptoms, and …